HeartBeam Cuts Costs Awaits FDA Decision
HeartBeam (NASDAQ:BEAT) reported a 23% decrease in cash burn to $3.4 million in Q2 2025, ending the period with $5.1 ...
Tag: HeartBeam
News Summarized. Time Saved. Bite-sized news briefs for busy people. No fluff, just facts.